94 related articles for article (PubMed ID: 14696459)
1. The in vitro effect of interferon-alpha 2a on CD95 expression of T cells in hepatitis B.
Karan MA; Oztürk S; Yenerel M; Erten N; Cefle K; Palanduz S; Tascioglu C
Hepatogastroenterology; 2003; 50(54):2031-4. PubMed ID: 14696459
[TBL] [Abstract][Full Text] [Related]
2. Effect of IFNalpha-2a on Fas expression and apoptosis rate of peripheral blood cytotoxic T cells in patients with hepatitis B.
Hou W; Liu KZ; Li MW; Wo JE
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):403-5. PubMed ID: 16109525
[TBL] [Abstract][Full Text] [Related]
3. Increase in CD95 (Fas/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena.
Ogawa S; Sakaguchi K; Takaki A; Shiraga K; Sawayama T; Mouri H; Miyashita M; Koide N; Tsuji T
J Gastroenterol Hepatol; 2000 Jan; 15(1):69-75. PubMed ID: 10719750
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
Kaser A; Nagata S; Tilg H
Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 and Fas expression in peripheral blood leukocytes of patients with alcoholic and autoimmune liver disorders.
Zwolak A; Surdacka A; Daniluk J
Hum Exp Toxicol; 2016 Aug; 35(8):799-807. PubMed ID: 26429926
[TBL] [Abstract][Full Text] [Related]
6. Measurement of circulating T cell subsets positive for Fas antigen (CD95) in patients with alcoholic hepatitis.
Ishimaru H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1999 Jun; 34(3):161-72. PubMed ID: 10424111
[TBL] [Abstract][Full Text] [Related]
7. Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.
Panasiuk A; Parfieniuk A; Zak J; Flisiak R
Liver Int; 2010 Mar; 30(3):472-8. PubMed ID: 19919570
[TBL] [Abstract][Full Text] [Related]
8. The expression of TLR-9, CD86, and CD95 phenotypes in circulating B cells of patients with chronic viral hepatitis B or C before and after antiviral therapy.
Zhao PW; Ma L; Ji HF; Yu L; Feng JY; Wang J; Liu MY; Jiang YF
Mediators Inflamm; 2015; 2015():762709. PubMed ID: 25892855
[TBL] [Abstract][Full Text] [Related]
9. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
Koukourakis GV; Baksevanis CN; Zambatis H; Gritzapis A; Maltezos E; Simopoulos C; Koukourakis MI
Int J Radiat Biol; 2009 Jan; 85(1):96-104. PubMed ID: 19205988
[TBL] [Abstract][Full Text] [Related]
10. CD95/Fas expression on peripheral blood T lymphocytes in patients with multiple sclerosis: effect of high-dose methylprednisolone therapy.
Petelin Z; Brinar V; Petravic D; Zurak N; Dubravcic K; Batinic D
Clin Neurol Neurosurg; 2004 Jun; 106(3):259-62. PubMed ID: 15177780
[TBL] [Abstract][Full Text] [Related]
11. Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD.
Domagała-Kulawik J; Hoser G; Dabrowska M; Chazan R
Respir Med; 2007 Jun; 101(6):1338-43. PubMed ID: 17118637
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.
Rodriguez B; Lederman MM; Jiang W; Bazdar DA; Gàrate K; Harding CV; Sieg SF
AIDS; 2006 Jun; 20(10):1379-89. PubMed ID: 16791012
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation.
Wang Y; Liu Y; Han R; Li Q; Yao Z; Niu W; Yuan Y; Tang Z; Zhu Z; Shen Z
J Gastroenterol Hepatol; 2010 Jan; 25(1):138-42. PubMed ID: 19817952
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
[TBL] [Abstract][Full Text] [Related]
16. Immunological response in chronic hepatitis C virus infection during interferon alpha therapy.
Panasiuk A; Prokopowicz D; Zak J
Hepatogastroenterology; 2004; 51(58):1088-92. PubMed ID: 15239252
[TBL] [Abstract][Full Text] [Related]
17. Immunological predictors of different responses to combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C.
Amaraa R; Mareckova H; Urbanek P; Fucikova T
J Gastroenterol; 2003; 38(3):254-9. PubMed ID: 12673448
[TBL] [Abstract][Full Text] [Related]
18. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.
Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A
Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
[TBL] [Abstract][Full Text] [Related]
20. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
